News|Videos|August 26, 2025

Protecting Older Adults From Severe COVID-19

Allergist and immunologist Juanita Mora, MD, urges vaccination, masking, and outreach to safeguard vulnerable communities.

Older adults remain at the highest risk for severe COVID-19 outcomes, and vaccination continues to be the most critical defense, according to Juanita Mora, MD, an allergist and immunologist in Chicago who serves largely Latino and African American communities.

“We know it affects the 65 and older population, and it hits them hard,” Mora said. Adults aged 65 years and older account for the majority of severe COVID-19 outcomes, representing about 70% of hospitalizations and 90% of deaths in the United States.

Beyond vaccination, Mora advises additional precautions for vulnerable groups. “Number one thing that I tell these 65 years and older population—mask,” she said. She added that long COVID is a major concern: “One in two of them who wind up being hospitalized end up having long symptoms, which might be wheezing, asthma, COPD, neurological, or even cardiac effects.”

Mora has been active in outreach and advocacy, speaking in English and Spanish to address misinformation. “I actually vaccinate my dad with the COVID-19 vaccine [on social media]. If I trusted in my own family, it gives them that message as well,” she said.

This fall, she is partnering with Walgreens and the American Lung Association to host a free vaccine clinic in Chicago’s Pilsen neighborhood. “People without insurance or immigrants can go ahead and get the vaccines for free,” Mora said.

“As the holidays are approaching, we need to make sure the whole family is vaccinated against COVID-19, flu, and RSV,” she concluded. “We want to keep our grandparents safe.”


Related to this article

FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak
As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.
NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy
The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.
Measles Update: October 9, 2026
The latest CDC numbers show a 5.0% increase of measles cases from week-to-week. The US total reached 4080 confirmed cases, 78% above all of 2025.